Cargando…
Dihydroartemisinin-Piperaquine Versus Chloroquine in the Treatment of Plasmodium vivax Malaria in Thailand: A Randomized Controlled Trial
Background. Chloroquine (CQ) remains the treatment of choice for Plasmodium vivax malaria. Initially confined to parts of Indonesia and Papua, resistance of P. vivax to CQ seems to be spreading, and alternative treatments are required. Methods. We conducted a randomized controlled study to compare t...
Autores principales: | Phyo, Aung Pyae, Lwin, Khin Maung, Price, Ric N., Ashley, Elizabeth A., Russell, Bruce, Sriprawat, Kanlaya, Lindegardh, Niklas, Singhasivanon, Pratap, White, Nicholas J., Nosten, François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193831/ https://www.ncbi.nlm.nih.gov/pubmed/22002979 http://dx.doi.org/10.1093/cid/cir631 |
Ejemplares similares
-
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2019) -
Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand
por: Rijken, Marcus J, et al.
Publicado: (2011) -
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2018) -
Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial
por: Awab, Ghulam Rahim, et al.
Publicado: (2010) -
Plasmodium vivax trophozoites insensitive to chloroquine
por: Sharrock, Wesley W, et al.
Publicado: (2008)